The global Embryo Selection Tool market size is predicted to grow from US$ 37.3 million in 2025 to US$ 49.2 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.
An Embryo Selection Tool is a technology-driven system used in in vitro fertilization (IVF) to help embryologists and fertility specialists identify the best-quality embryos for implantation. These tools use AI, time-lapse imaging, and genetic screening to improve pregnancy success rates and reduce subjectivity in the embryo grading process.
Key Features
- Market growth from US$ 37.3 million in 2025 to US$ 49.2 million in 2031
- CAGR of 4.7% from 2025 through 2031
Segmentation by Type
- Web-based
- Cloud-based
Segmentation by Application
- Hospital
- Clinic
- Other
Market by Region
- Americas
- APAC
- Europe
- Middle East & Africa
Company's Coverage
- Vitrolife
- Genea BIOMEDX
- MIM Fertility
- Alife Health
- Fairtility
- ASTEC CO., Ltd
- Care Fertility
- Cycle Clarity
- KritiKal Solutions
- ImVitro
Key Questions Addressed in this Report
Frequently Asked Questions
What is the USP of the report? expand_more
Embryo Selection Tool report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Embryo Selection Tool report is categorised based on following features:
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Embryo Selection Tool report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.